CytoMed Therapeutics Ltd (GDTC) stock
GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.78+0.01 (+1.18%)
Close on Nov 17, 2026Market cap $9.26MP/E –Yield –
CytoMed Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
CytoMed Therapeutics's total debt was 409.50K SGD at Dec 31, 2025. For fiscal 2025 it was 409.50K SGD, down 5.2% from the year before. The highest annual figure on record is 924.81K SGD in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 409.50K SGD | -5.2% |
| FY2024 | Dec 31, 2024 | 431.96K SGD | -2.2% |
| FY2023 | Dec 31, 2023 | 441.70K SGD | -45.0% |
| FY2022 | Dec 31, 2022 | 803.61K SGD | -13.1% |
| FY2021 | Dec 31, 2021 | 924.81K SGD | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | 409.50K SGD | -55.7% |
| Q4 FY2024 | Dec 31, 2024 | 431.96K SGD | – |
| Q4 FY2023 | Dec 31, 2023 | 441.70K SGD | – |
| Q4 FY2022 | Dec 31, 2022 | 803.61K SGD | – |
| Q4 FY2021 | Dec 31, 2021 | 924.81K SGD | – |
See a number that looks wrong?